| 1651 |
LORANIB |
LORLATINIB 25 MG |
TABLET |
BOTTLE |
TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE OR ROSI POSITIVE METASTATIC NON SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON IN WHICHTHE DISEASE OF KIA HAS SPREAD TO THE STAGE |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 0935/22 |
06-DEC-2022 |
05-DEC-2025 |
View |
| 1652 |
LORAPLATZ |
LORLATINIB 100 MG |
TABLET |
BOTTLE |
TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE OR ROSI POSITIVE METASTATIC NON SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
03 L 0956/23 |
17-JUN-2025 |
16-JUN-2030 |
View |
| 1653 |
LORATTADIN |
LORATADINE 10 MG |
TABLET |
BLISTERPACK |
TO RELIEVE SYMPTOMS RELATED TO ALLERGIC RHINITIS, SUCH AS SNEEZING, RUNNY NOSE, ITCHY NOSE, ITCHY NOSE, STUFFY NOSE, ITCHY EYES AND BURNING SENSATION |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
07 L 1134/24 |
12-JUL-2024 |
2027-07-11 |
View |
| 1654 |
L'OSEM-14 |
SEMAGLUTIDE 14 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS. |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
06 L 1121/24 |
01-JUL-2024 |
31-JUN-2027 |
View |
| 1655 |
L'OSEM-3 |
SEMAGLUTIDE 3 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS. |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
06 L 1123/24 |
01-JUL-2024 |
31-JUN-2027 |
View |
| 1656 |
L'OSEM-7 |
SEMAGLUTIDE 7 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS. |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
06 L 1122/24 |
01-JUL-2024 |
31-JUN-2027 |
View |
| 1657 |
METFORMIN-500 |
METFORMIN HYDROCHLORIDE 500 MG |
TABLET |
BLISTERPACK |
TREAMENT OF DIABETE MELITUS TYPE 2 |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
11 L 0936/22 |
06-DEC-2022 |
05-DEC-2025 |
View |
| 1658 |
MITOSIS |
MITOTANE 500 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH INOPERABLE, FUNCTIONAL OR NONFUNCTIONAL, ADRENAL CORTICAL CARCINOMA |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
04 L 1346/25 |
27-MAY-2025 |
26-MAY-2030 |
View |
| 1659 |
OMIRAZO |
OMEPRAZOLE 20 MG |
CAPSULE |
BLISTERPACK |
FOR PEPTIC ULCER(STOMACH, DUODENUM), ANTI-EPIDEMIC ESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME(GASTRINOMA) |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
12 L 1051/23 |
15-JAN-2024 |
14-JAN-2027 |
View |
| 1660 |
OMIRAZO |
OMEPRAZOLE 40 MG |
CAPSULE |
BLISTERPACK |
FOR PEPTIC ULCER(STOMACH, DUODENUM), ANTI-EPIDEMIC ESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME(GASTRINOMA) |
NULL |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
LAOS |
CERTIFICATE RELEASED |
12 L 1052/23 |
15-JAN-2024 |
14-JAN-2027 |
View |
